Yingru Zhou awarded Research Ireland’s Enterprise Partnership Scheme scholarship, partnered with Breakthrough Cancer Research
Yingru Zhou has been awarded Research Ireland’s Enterprise Partnership Scheme scholarship, partnered with Breakthrough Cancer Research.
The project, EPSPG/2024/1846, titled Modulation Of carbon Nanoparticles for pAncReatic Cancer tHerapy (MONARCH), aims to enhance cancer treatment by developing drug delivery systems for more precise and efficient targeting of cancer cells.
The research focuses on modifying two types of carbon nanoparticles with targeting agents and chemotherapy drugs. These modifications will enable the nanoparticles to selectively target cancer cells and release the drug within the tumour microenvironment. Subsequent cellular experiments will assess the system’s targeting ability, efficiency, and safety.
The success of this study could lead to the emergence of a new class of drug delivery systems. These systems would enable the use of lower drug doses, reduce side effects, and improve treatment efficacy, ultimately increasing survival rates and improving the quality of life for cancer patients.
Silvia Giordani
Full Professor Chair of Nanomaterials
My research interests are in the design, synthesis, and characterization of hybrid smart nanomaterials for biomedical, energy and environmental applications